Hanusch-Enserer U - Search Results

1

Increased C282Y heterozygosity in gestational diabetes.

Cauza E, Hanusch-Enserer U, Bischof M, Spak M, Kostner K, Tammaa A, Dunky A, Ferenci P. Cauza E, et al. Fetal Diagn Ther. 2005 Sep-Oct;20(5):349-54. doi: 10.1159/000086811. Fetal Diagn Ther. 2005. PMID: 16113552

2

HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis.

Cauza E, Hanusch-Enserer U, Etemad M, Köller M, Kostner K, Georg P, Dunky A, Ferenci P. Cauza E, et al. Clin Exp Rheumatol. 2005 Jan-Feb;23(1):7-12. Clin Exp Rheumatol. 2005. PMID: 15789881

3

The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus.

Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A, Haber P. Cauza E, et al. Arch Phys Med Rehabil. 2005 Aug;86(8):1527-33. doi: 10.1016/j.apmr.2005.01.007. Arch Phys Med Rehabil. 2005. PMID: 16084803 Clinical Trial.

4

The metabolic effects of long term exercise in Type 2 Diabetes patients.

Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P. Cauza E, et al. Wien Med Wochenschr. 2006 Sep;156(17-18):515-9. doi: 10.1007/s10354-006-0337-y. Wien Med Wochenschr. 2006. PMID: 17041809 Clinical Trial.

5

Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system.

Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P. Cauza E, et al. Eur J Clin Invest. 2005 Dec;35(12):745-51. doi: 10.1111/j.1365-2362.2005.01573.x. Eur J Clin Invest. 2005. PMID: 16313250 Clinical Trial.

6

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.

Cauza E, Spak M, Cauza K, Hanusch-Enserer U, Dunky A, Wagner E. Cauza E, et al. Rheumatol Int. 2002 Nov;22(6):227-32. doi: 10.1007/s00296-002-0246-3. Epub 2002 Sep 4. Rheumatol Int. 2002. PMID: 12426660 Clinical Trial.

7

Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.

Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K. Cauza E, et al. Wien Klin Wochenschr. 2002 Dec 30;114(23-24):1004-7. Wien Klin Wochenschr. 2002. PMID: 12635469

8

Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese.

Hanusch-Enserer U, Hermann KM, Cauza E, Spak M, Mähr B, Dunky A, Rosen HR, Köller U, Prager R. Hanusch-Enserer U, et al. Obes Res. 2003 Jun;11(6):695-8. doi: 10.1038/oby.2003.99. Obes Res. 2003. PMID: 12805390 Free article.

9

Continuous glucose monitoring in diabetic long distance runners.

Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, Haber P. Cauza E, et al. Int J Sports Med. 2005 Nov;26(9):774-80. doi: 10.1055/s-2004-830561. Int J Sports Med. 2005. PMID: 16237624

10

Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.

Cauza E, Hanusch-Enserer U, Frischmuth K, Fabian B, Dunky A, Kostner K. Cauza E, et al. J Clin Pharm Ther. 2006 Apr;31(2):149-52. doi: 10.1111/j.1365-2710.2006.00715.x. J Clin Pharm Ther. 2006. PMID: 16635048 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters